SUPPREMOL
SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
SUPPREMOL
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2002-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.suppremol.com
Total Employee:
11+
Status:
Active
Contact:
49 89 30 90 50 680
Email Addresses:
[email protected]
Total Funding:
71 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Founder
Investors List
BioMedPartners
BioMedPartners investment in Series D - SuppreMol
MIG Capital
MIG Capital investment in Series D - SuppreMol
Santo Holding
Santo Holding investment in Series D - SuppreMol
FCP Biotech Holding
FCP Biotech Holding investment in Series D - SuppreMol
MIG Capital
MIG Capital investment in Series D - SuppreMol
Bayern Kapital
Bayern Kapital investment in Series C - SuppreMol
Santo Holding
Santo Holding investment in Series C - SuppreMol
BioMedPartners
BioMedPartners investment in Series C - SuppreMol
KfW
KfW investment in Series C - SuppreMol
FCP Biotech Holding
FCP Biotech Holding investment in Series C - SuppreMol
Official Site Inspections
http://www.suppremol.com Semrush global rank: 13.6 M Semrush visits lastest month: 75
Unable to get host informations!!!
More informations about "SuppreMol"
SuppreMol Company Profile 2024: Valuation, Investors ... - PitchBook
SuppreMol General Information Description. Developer of therapeutics for the treatment of autoimmune diseases and allergic diseases. The company is focused on development of …See details»
SuppreMol - Ownership and Business Overview - Mergr
Mar 4, 2015 SuppreMol is a life science company. Life Science M&A Summary in 2015. Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The …See details»
SuppreMol - Funding, Financials, Valuation & Investors - Crunchbase
SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
SuppreMol - Products, Competitors, Financials, Employees, …
SuppreMol GmbH Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, …See details»
SuppreMol GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Explore SuppreMol GmbH with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 2 news, and 8 literature, Drug:Valziflocept, SM-401.See details»
SuppreMol - VentureRadar
SuppreMol follows two distinct strategies to develop novel treatment options for autoimmune and chronic inflammatory diseases as well as allergies. Since 2015 they are part of Baxalta. …See details»
Suppremol GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Suppremol GmbH of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»
SuppreMol GmbH - life-sciences-europe.com
Upcoming Events. Life Science Start-up Day 2024 Göttingen; Pittcon 2024 San Diego; BIO CEO & Investor Conference 2024 New York; CAR-TCR Europe 2024 LondonSee details»
SuppreMol - Crunchbase
SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.See details»
SuppreMol - Company Profile - Tracxn
SuppreMol - Developer of therapeutics for the treatment of autoimmune diseases. Acquired by Baxter. Raised a total funding of $71M over 5 rounds from 7 investors. Founded by Peter …See details»
SuppreMol GmbH - Martinsried, Germany - bionity.com
Jul 27, 2012 SuppreMol GmbH announced that the European Commission has granted orphan medicinal product designation for Suppre- Mol's lead product SM101, a recombinant ... Read …See details»
SuppreMol’s Competitors, Revenue, Number of Employees ... - Owler
SuppreMol’s Profile, Revenue and Employees. SuppreMol is a biotechnology firm that develops novel therapeutics for the treatment of autoimmune diseases. SuppreMol’s primary …See details»
Baxter's BioScience Business Acquires Biopharmaceutical Company …
Mar 4, 2015 SuppreMol was founded as a spin-off from the laboratory of Prof. Dr. Robert Huber, Nobel Prize Laureate in Chemistry 1988, at the Max Planck Institute for Biochemistry in …See details»
SuppreMol - Raised $71M Funding from 7 investors - Tracxn
Dec 10, 2024 SuppreMol has raised a total funding of $71M over 5 rounds from 7 investors. Investors include KfW, BioMedPartners and 5 others. Their latest funding round was of …See details»
Baxter International acquires SuppreMol - 2015-03-05 - Crunchbase
Mar 5, 2015 SuppreMol SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders. Acquiring Organization: Baxter …See details»
suppremol.com - Takeda - Better Health, Bright... - Suppremol
Suppremol.com. Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter futu... sur.ly Takeda - Better Health, Brighter …See details»
Baxter buys SuppreMol for $225m - Pharmaceutical Technology
Mar 5, 2015 The company will continue to operate SuppreMol’s operations in Munich, in addition to the portfolio.SuppreMol’s pipeline comprises lead candidate SM101, an investigational …See details»
Supreme Organization
It’s hard to express just how much Jodie Watson of Supreme Organization has helped my life. Starting a new job is hard enough, but moving to a new city and apartment loaded with boxes …See details»
SuppreMol - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of SuppreMol includes 26 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, SuppreMol has 1 …See details»